Infigratinib acetate

SKU: orb1738478

Description

Infigratinib acetate (BGJ398 acetate) is an orally available, pan-FGFR kinase inhibitor with antineoplastic activity. It is used in research targeting FGFR-altered cancers, such as cholangiocarcinoma, and has demonstrated efficacy in both in vitro cellular assays and in vivo xenograft models.

Images & Validation

−

Key Properties

−

CAS Number	1310746-17-8
MW	620.53
Formula	C₂₈H₃₅Cl₂N₇O₅
SMILES	CC(O)=O.CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1
Target	Others

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

91618031 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols